nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—CYP1A2—Carmustine—lymphatic system cancer	0.179	0.246	CbGbCtD
Gemfibrozil—CYP2C19—Teniposide—lymphatic system cancer	0.13	0.18	CbGbCtD
Gemfibrozil—CYP2C9—Teniposide—lymphatic system cancer	0.108	0.149	CbGbCtD
Gemfibrozil—SLCO1B1—Methotrexate—lymphatic system cancer	0.107	0.147	CbGbCtD
Gemfibrozil—CYP3A4—Cytarabine—lymphatic system cancer	0.064	0.0881	CbGbCtD
Gemfibrozil—CYP3A4—Teniposide—lymphatic system cancer	0.063	0.0868	CbGbCtD
Gemfibrozil—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0441	0.0607	CbGbCtD
Gemfibrozil—CYP3A4—Vincristine—lymphatic system cancer	0.0303	0.0418	CbGbCtD
Gemfibrozil—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00169	0.00617	CcSEcCtD
Gemfibrozil—Alopecia—Teniposide—lymphatic system cancer	0.0016	0.00582	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Fludarabine—lymphatic system cancer	0.00158	0.00576	CcSEcCtD
Gemfibrozil—Anaemia—Teniposide—lymphatic system cancer	0.00145	0.0053	CcSEcCtD
Gemfibrozil—Leukopenia—Teniposide—lymphatic system cancer	0.00141	0.00513	CcSEcCtD
Gemfibrozil—Alopecia—Fludarabine—lymphatic system cancer	0.0014	0.00512	CcSEcCtD
Gemfibrozil—Bone marrow depression—Methotrexate—lymphatic system cancer	0.00139	0.00506	CcSEcCtD
Gemfibrozil—Pancytopenia—Bleomycin—lymphatic system cancer	0.00138	0.00504	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Carmustine—lymphatic system cancer	0.00135	0.00494	CcSEcCtD
Gemfibrozil—Chest pain—Teniposide—lymphatic system cancer	0.00134	0.00488	CcSEcCtD
Gemfibrozil—Weight decreased—Bleomycin—lymphatic system cancer	0.00131	0.0048	CcSEcCtD
Gemfibrozil—Muscular weakness—Carmustine—lymphatic system cancer	0.00129	0.00472	CcSEcCtD
Gemfibrozil—Confusional state—Teniposide—lymphatic system cancer	0.00129	0.00472	CcSEcCtD
Gemfibrozil—Oedema—Teniposide—lymphatic system cancer	0.00128	0.00468	CcSEcCtD
Gemfibrozil—Anaemia—Fludarabine—lymphatic system cancer	0.00128	0.00466	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00126	0.00458	CcSEcCtD
Gemfibrozil—Abdominal pain upper—Mitoxantrone—lymphatic system cancer	0.00125	0.00455	CcSEcCtD
Gemfibrozil—Leukopenia—Fludarabine—lymphatic system cancer	0.00124	0.00451	CcSEcCtD
Gemfibrozil—Muscular weakness—Vincristine—lymphatic system cancer	0.00124	0.00451	CcSEcCtD
Gemfibrozil—Pruritus—Mechlorethamine—lymphatic system cancer	0.00123	0.00449	CcSEcCtD
Gemfibrozil—Cough—Fludarabine—lymphatic system cancer	0.00121	0.0044	CcSEcCtD
Gemfibrozil—Pancytopenia—Carmustine—lymphatic system cancer	0.0012	0.0044	CcSEcCtD
Gemfibrozil—Convulsion—Fludarabine—lymphatic system cancer	0.0012	0.00437	CcSEcCtD
Gemfibrozil—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00119	0.00434	CcSEcCtD
Gemfibrozil—Myalgia—Fludarabine—lymphatic system cancer	0.00118	0.00429	CcSEcCtD
Gemfibrozil—Arthralgia—Fludarabine—lymphatic system cancer	0.00118	0.00429	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.00116	0.00422	CcSEcCtD
Gemfibrozil—Pancytopenia—Vincristine—lymphatic system cancer	0.00115	0.0042	CcSEcCtD
Gemfibrozil—Confusional state—Fludarabine—lymphatic system cancer	0.00114	0.00415	CcSEcCtD
Gemfibrozil—Depression—Carmustine—lymphatic system cancer	0.00113	0.00411	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00113	0.00411	CcSEcCtD
Gemfibrozil—Oedema—Fludarabine—lymphatic system cancer	0.00113	0.00411	CcSEcCtD
Gemfibrozil—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.00112	0.00409	CcSEcCtD
Gemfibrozil—Erectile dysfunction—Vincristine—lymphatic system cancer	0.00112	0.00407	CcSEcCtD
Gemfibrozil—Renal failure—Carmustine—lymphatic system cancer	0.00111	0.00406	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.00111	0.00405	CcSEcCtD
Gemfibrozil—Vomiting—Mechlorethamine—lymphatic system cancer	0.00111	0.00404	CcSEcCtD
Gemfibrozil—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00111	0.00403	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.00111	0.00403	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.0011	0.00403	CcSEcCtD
Gemfibrozil—Urinary tract infection—Carmustine—lymphatic system cancer	0.0011	0.00401	CcSEcCtD
Gemfibrozil—Rash—Mechlorethamine—lymphatic system cancer	0.0011	0.004	CcSEcCtD
Gemfibrozil—Dermatitis—Mechlorethamine—lymphatic system cancer	0.0011	0.004	CcSEcCtD
Gemfibrozil—Weight decreased—Vincristine—lymphatic system cancer	0.0011	0.004	CcSEcCtD
Gemfibrozil—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.00109	0.00396	CcSEcCtD
Gemfibrozil—Depression—Vincristine—lymphatic system cancer	0.00108	0.00393	CcSEcCtD
Gemfibrozil—Weight decreased—Mitoxantrone—lymphatic system cancer	0.00107	0.00389	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.00106	0.00386	CcSEcCtD
Gemfibrozil—Feeling abnormal—Teniposide—lymphatic system cancer	0.00106	0.00386	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00105	0.00383	CcSEcCtD
Gemfibrozil—Renal failure—Mitoxantrone—lymphatic system cancer	0.00103	0.00377	CcSEcCtD
Gemfibrozil—Nausea—Mechlorethamine—lymphatic system cancer	0.00103	0.00377	CcSEcCtD
Gemfibrozil—Alopecia—Bleomycin—lymphatic system cancer	0.00103	0.00375	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00103	0.00375	CcSEcCtD
Gemfibrozil—Jaundice—Mitoxantrone—lymphatic system cancer	0.00102	0.00374	CcSEcCtD
Gemfibrozil—Urinary tract infection—Mitoxantrone—lymphatic system cancer	0.00102	0.00373	CcSEcCtD
Gemfibrozil—Urticaria—Teniposide—lymphatic system cancer	0.00102	0.00372	CcSEcCtD
Gemfibrozil—Abdominal pain—Teniposide—lymphatic system cancer	0.00101	0.0037	CcSEcCtD
Gemfibrozil—Paraesthesia—Fludarabine—lymphatic system cancer	0.00101	0.00369	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00101	0.00369	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Carmustine—lymphatic system cancer	0.000998	0.00364	CcSEcCtD
Gemfibrozil—Dyspepsia—Fludarabine—lymphatic system cancer	0.000992	0.00362	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000973	0.00355	CcSEcCtD
Gemfibrozil—Fatigue—Fludarabine—lymphatic system cancer	0.000972	0.00355	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Vincristine—lymphatic system cancer	0.000964	0.00352	CcSEcCtD
Gemfibrozil—Pain—Fludarabine—lymphatic system cancer	0.000964	0.00352	CcSEcCtD
Gemfibrozil—Constipation—Fludarabine—lymphatic system cancer	0.000964	0.00352	CcSEcCtD
Gemfibrozil—Vasculitis—Methotrexate—lymphatic system cancer	0.000959	0.0035	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Vincristine—lymphatic system cancer	0.000952	0.00348	CcSEcCtD
Gemfibrozil—Eye disorder—Carmustine—lymphatic system cancer	0.000949	0.00346	CcSEcCtD
Gemfibrozil—Rhinitis—Mitoxantrone—lymphatic system cancer	0.000946	0.00345	CcSEcCtD
Gemfibrozil—Anaemia—Bleomycin—lymphatic system cancer	0.000936	0.00341	CcSEcCtD
Gemfibrozil—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000929	0.00339	CcSEcCtD
Gemfibrozil—Asthenia—Teniposide—lymphatic system cancer	0.00092	0.00336	CcSEcCtD
Gemfibrozil—Pruritus—Teniposide—lymphatic system cancer	0.000907	0.00331	CcSEcCtD
Gemfibrozil—Leukopenia—Bleomycin—lymphatic system cancer	0.000906	0.00331	CcSEcCtD
Gemfibrozil—Alopecia—Carmustine—lymphatic system cancer	0.000897	0.00327	CcSEcCtD
Gemfibrozil—Mental disorder—Carmustine—lymphatic system cancer	0.000889	0.00325	CcSEcCtD
Gemfibrozil—Cough—Bleomycin—lymphatic system cancer	0.000884	0.00322	CcSEcCtD
Gemfibrozil—Diarrhoea—Teniposide—lymphatic system cancer	0.000877	0.0032	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Vincristine—lymphatic system cancer	0.000873	0.00319	CcSEcCtD
Gemfibrozil—Myalgia—Bleomycin—lymphatic system cancer	0.000862	0.00315	CcSEcCtD
Gemfibrozil—Chest pain—Bleomycin—lymphatic system cancer	0.000862	0.00315	CcSEcCtD
Gemfibrozil—Alopecia—Vincristine—lymphatic system cancer	0.000856	0.00313	CcSEcCtD
Gemfibrozil—Mental disorder—Vincristine—lymphatic system cancer	0.000849	0.0031	CcSEcCtD
Gemfibrozil—Alopecia—Mitoxantrone—lymphatic system cancer	0.000834	0.00304	CcSEcCtD
Gemfibrozil—Confusional state—Bleomycin—lymphatic system cancer	0.000833	0.00304	CcSEcCtD
Gemfibrozil—Vision blurred—Carmustine—lymphatic system cancer	0.000833	0.00304	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000826	0.00302	CcSEcCtD
Gemfibrozil—Oedema—Bleomycin—lymphatic system cancer	0.000826	0.00302	CcSEcCtD
Gemfibrozil—Anaemia—Carmustine—lymphatic system cancer	0.000817	0.00298	CcSEcCtD
Gemfibrozil—Vomiting—Teniposide—lymphatic system cancer	0.000815	0.00298	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000809	0.00295	CcSEcCtD
Gemfibrozil—Asthenia—Fludarabine—lymphatic system cancer	0.000809	0.00295	CcSEcCtD
Gemfibrozil—Rash—Teniposide—lymphatic system cancer	0.000809	0.00295	CcSEcCtD
Gemfibrozil—Dermatitis—Teniposide—lymphatic system cancer	0.000808	0.00295	CcSEcCtD
Gemfibrozil—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000805	0.00294	CcSEcCtD
Gemfibrozil—Headache—Teniposide—lymphatic system cancer	0.000803	0.00293	CcSEcCtD
Gemfibrozil—Pruritus—Fludarabine—lymphatic system cancer	0.000797	0.00291	CcSEcCtD
Gemfibrozil—Leukopenia—Carmustine—lymphatic system cancer	0.000791	0.00289	CcSEcCtD
Gemfibrozil—Anaemia—Vincristine—lymphatic system cancer	0.00078	0.00285	CcSEcCtD
Gemfibrozil—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000774	0.00283	CcSEcCtD
Gemfibrozil—Photosensitivity—Methotrexate—lymphatic system cancer	0.000774	0.00282	CcSEcCtD
Gemfibrozil—Diarrhoea—Fludarabine—lymphatic system cancer	0.000771	0.00281	CcSEcCtD
Gemfibrozil—Convulsion—Carmustine—lymphatic system cancer	0.000766	0.00279	CcSEcCtD
Gemfibrozil—Nausea—Teniposide—lymphatic system cancer	0.000762	0.00278	CcSEcCtD
Gemfibrozil—Anaemia—Mitoxantrone—lymphatic system cancer	0.000759	0.00277	CcSEcCtD
Gemfibrozil—Vertigo—Vincristine—lymphatic system cancer	0.000758	0.00277	CcSEcCtD
Gemfibrozil—Leukopenia—Vincristine—lymphatic system cancer	0.000755	0.00276	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000753	0.00275	CcSEcCtD
Gemfibrozil—Chest pain—Carmustine—lymphatic system cancer	0.000752	0.00275	CcSEcCtD
Gemfibrozil—Myalgia—Carmustine—lymphatic system cancer	0.000752	0.00275	CcSEcCtD
Gemfibrozil—Paraesthesia—Bleomycin—lymphatic system cancer	0.000742	0.00271	CcSEcCtD
Gemfibrozil—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000735	0.00268	CcSEcCtD
Gemfibrozil—Convulsion—Vincristine—lymphatic system cancer	0.000731	0.00267	CcSEcCtD
Gemfibrozil—Confusional state—Carmustine—lymphatic system cancer	0.000727	0.00265	CcSEcCtD
Gemfibrozil—Oedema—Carmustine—lymphatic system cancer	0.000721	0.00263	CcSEcCtD
Gemfibrozil—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00072	0.00263	CcSEcCtD
Gemfibrozil—Myalgia—Vincristine—lymphatic system cancer	0.000718	0.00262	CcSEcCtD
Gemfibrozil—Cough—Mitoxantrone—lymphatic system cancer	0.000717	0.00262	CcSEcCtD
Gemfibrozil—Vomiting—Fludarabine—lymphatic system cancer	0.000717	0.00261	CcSEcCtD
Gemfibrozil—Convulsion—Mitoxantrone—lymphatic system cancer	0.000712	0.0026	CcSEcCtD
Gemfibrozil—Rash—Fludarabine—lymphatic system cancer	0.000711	0.00259	CcSEcCtD
Gemfibrozil—Dermatitis—Fludarabine—lymphatic system cancer	0.00071	0.00259	CcSEcCtD
Gemfibrozil—Pain—Bleomycin—lymphatic system cancer	0.000707	0.00258	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000706	0.00258	CcSEcCtD
Gemfibrozil—Headache—Fludarabine—lymphatic system cancer	0.000706	0.00258	CcSEcCtD
Gemfibrozil—Myalgia—Mitoxantrone—lymphatic system cancer	0.0007	0.00255	CcSEcCtD
Gemfibrozil—Arthralgia—Mitoxantrone—lymphatic system cancer	0.0007	0.00255	CcSEcCtD
Gemfibrozil—Chest pain—Mitoxantrone—lymphatic system cancer	0.0007	0.00255	CcSEcCtD
Gemfibrozil—Oedema—Vincristine—lymphatic system cancer	0.000689	0.00251	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000689	0.00251	CcSEcCtD
Gemfibrozil—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000681	0.00248	CcSEcCtD
Gemfibrozil—Confusional state—Mitoxantrone—lymphatic system cancer	0.000676	0.00247	CcSEcCtD
Gemfibrozil—Nervous system disorder—Vincristine—lymphatic system cancer	0.000675	0.00246	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000674	0.00246	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000671	0.00245	CcSEcCtD
Gemfibrozil—Oedema—Mitoxantrone—lymphatic system cancer	0.000671	0.00245	CcSEcCtD
Gemfibrozil—Nausea—Fludarabine—lymphatic system cancer	0.000669	0.00244	CcSEcCtD
Gemfibrozil—Shock—Mitoxantrone—lymphatic system cancer	0.00066	0.00241	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000657	0.0024	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000657	0.0024	CcSEcCtD
Gemfibrozil—Urticaria—Bleomycin—lymphatic system cancer	0.000656	0.0024	CcSEcCtD
Gemfibrozil—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000651	0.00238	CcSEcCtD
Gemfibrozil—Paraesthesia—Carmustine—lymphatic system cancer	0.000648	0.00236	CcSEcCtD
Gemfibrozil—Somnolence—Carmustine—lymphatic system cancer	0.000641	0.00234	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000628	0.00229	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000627	0.00229	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000623	0.00227	CcSEcCtD
Gemfibrozil—Paraesthesia—Vincristine—lymphatic system cancer	0.000618	0.00226	CcSEcCtD
Gemfibrozil—Constipation—Carmustine—lymphatic system cancer	0.000617	0.00225	CcSEcCtD
Gemfibrozil—Pain—Carmustine—lymphatic system cancer	0.000617	0.00225	CcSEcCtD
Gemfibrozil—Breast disorder—Methotrexate—lymphatic system cancer	0.000614	0.00224	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000611	0.00223	CcSEcCtD
Gemfibrozil—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000602	0.0022	CcSEcCtD
Gemfibrozil—Somnolence—Mitoxantrone—lymphatic system cancer	0.000596	0.00218	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000594	0.00217	CcSEcCtD
Gemfibrozil—Feeling abnormal—Carmustine—lymphatic system cancer	0.000594	0.00217	CcSEcCtD
Gemfibrozil—Fatigue—Vincristine—lymphatic system cancer	0.000594	0.00217	CcSEcCtD
Gemfibrozil—Asthenia—Bleomycin—lymphatic system cancer	0.000593	0.00216	CcSEcCtD
Gemfibrozil—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00059	0.00215	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00059	0.00215	CcSEcCtD
Gemfibrozil—Pain—Vincristine—lymphatic system cancer	0.000589	0.00215	CcSEcCtD
Gemfibrozil—Constipation—Vincristine—lymphatic system cancer	0.000589	0.00215	CcSEcCtD
Gemfibrozil—Pruritus—Bleomycin—lymphatic system cancer	0.000585	0.00213	CcSEcCtD
Gemfibrozil—Eosinophilia—Methotrexate—lymphatic system cancer	0.000582	0.00212	CcSEcCtD
Gemfibrozil—Fatigue—Mitoxantrone—lymphatic system cancer	0.000578	0.00211	CcSEcCtD
Gemfibrozil—Pancreatitis—Methotrexate—lymphatic system cancer	0.000576	0.0021	CcSEcCtD
Gemfibrozil—Pain—Mitoxantrone—lymphatic system cancer	0.000573	0.00209	CcSEcCtD
Gemfibrozil—Constipation—Mitoxantrone—lymphatic system cancer	0.000573	0.00209	CcSEcCtD
Gemfibrozil—Abdominal pain—Carmustine—lymphatic system cancer	0.00057	0.00208	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000563	0.00205	CcSEcCtD
Gemfibrozil—Pancytopenia—Methotrexate—lymphatic system cancer	0.000558	0.00204	CcSEcCtD
Gemfibrozil—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000553	0.00202	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000548	0.002	CcSEcCtD
Gemfibrozil—Abdominal pain—Vincristine—lymphatic system cancer	0.000544	0.00199	CcSEcCtD
Gemfibrozil—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000541	0.00197	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000536	0.00196	CcSEcCtD
Gemfibrozil—Urticaria—Mitoxantrone—lymphatic system cancer	0.000533	0.00194	CcSEcCtD
Gemfibrozil—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00053	0.00193	CcSEcCtD
Gemfibrozil—Vomiting—Bleomycin—lymphatic system cancer	0.000525	0.00192	CcSEcCtD
Gemfibrozil—Depression—Methotrexate—lymphatic system cancer	0.000522	0.00191	CcSEcCtD
Gemfibrozil—Rash—Bleomycin—lymphatic system cancer	0.000521	0.0019	CcSEcCtD
Gemfibrozil—Dermatitis—Bleomycin—lymphatic system cancer	0.000521	0.0019	CcSEcCtD
Gemfibrozil—Asthenia—Carmustine—lymphatic system cancer	0.000518	0.00189	CcSEcCtD
Gemfibrozil—Renal failure—Methotrexate—lymphatic system cancer	0.000515	0.00188	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000495	0.00181	CcSEcCtD
Gemfibrozil—Asthenia—Vincristine—lymphatic system cancer	0.000494	0.0018	CcSEcCtD
Gemfibrozil—Diarrhoea—Carmustine—lymphatic system cancer	0.000494	0.0018	CcSEcCtD
Gemfibrozil—Nausea—Bleomycin—lymphatic system cancer	0.000491	0.00179	CcSEcCtD
Gemfibrozil—Asthenia—Mitoxantrone—lymphatic system cancer	0.000481	0.00176	CcSEcCtD
Gemfibrozil—Dizziness—Carmustine—lymphatic system cancer	0.000477	0.00174	CcSEcCtD
Gemfibrozil—Diarrhoea—Vincristine—lymphatic system cancer	0.000471	0.00172	CcSEcCtD
Gemfibrozil—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000459	0.00167	CcSEcCtD
Gemfibrozil—Vomiting—Carmustine—lymphatic system cancer	0.000459	0.00167	CcSEcCtD
Gemfibrozil—Dizziness—Vincristine—lymphatic system cancer	0.000455	0.00166	CcSEcCtD
Gemfibrozil—Rash—Carmustine—lymphatic system cancer	0.000455	0.00166	CcSEcCtD
Gemfibrozil—Dermatitis—Carmustine—lymphatic system cancer	0.000454	0.00166	CcSEcCtD
Gemfibrozil—Headache—Carmustine—lymphatic system cancer	0.000452	0.00165	CcSEcCtD
Gemfibrozil—Eye disorder—Methotrexate—lymphatic system cancer	0.000439	0.0016	CcSEcCtD
Gemfibrozil—Vomiting—Vincristine—lymphatic system cancer	0.000438	0.0016	CcSEcCtD
Gemfibrozil—Rash—Vincristine—lymphatic system cancer	0.000434	0.00158	CcSEcCtD
Gemfibrozil—Dermatitis—Vincristine—lymphatic system cancer	0.000434	0.00158	CcSEcCtD
Gemfibrozil—Headache—Vincristine—lymphatic system cancer	0.000431	0.00157	CcSEcCtD
Gemfibrozil—Nausea—Carmustine—lymphatic system cancer	0.000428	0.00156	CcSEcCtD
Gemfibrozil—Vomiting—Mitoxantrone—lymphatic system cancer	0.000426	0.00156	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000424	0.00155	CcSEcCtD
Gemfibrozil—Rash—Mitoxantrone—lymphatic system cancer	0.000423	0.00154	CcSEcCtD
Gemfibrozil—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000422	0.00154	CcSEcCtD
Gemfibrozil—Headache—Mitoxantrone—lymphatic system cancer	0.00042	0.00153	CcSEcCtD
Gemfibrozil—Alopecia—Methotrexate—lymphatic system cancer	0.000416	0.00152	CcSEcCtD
Gemfibrozil—Mental disorder—Methotrexate—lymphatic system cancer	0.000412	0.0015	CcSEcCtD
Gemfibrozil—Nausea—Vincristine—lymphatic system cancer	0.000409	0.00149	CcSEcCtD
Gemfibrozil—Dysgeusia—Methotrexate—lymphatic system cancer	0.000401	0.00146	CcSEcCtD
Gemfibrozil—Nausea—Mitoxantrone—lymphatic system cancer	0.000398	0.00145	CcSEcCtD
Gemfibrozil—Vision blurred—Methotrexate—lymphatic system cancer	0.000386	0.00141	CcSEcCtD
Gemfibrozil—Anaemia—Methotrexate—lymphatic system cancer	0.000378	0.00138	CcSEcCtD
Gemfibrozil—Vertigo—Methotrexate—lymphatic system cancer	0.000368	0.00134	CcSEcCtD
Gemfibrozil—Leukopenia—Methotrexate—lymphatic system cancer	0.000366	0.00134	CcSEcCtD
Gemfibrozil—Cough—Methotrexate—lymphatic system cancer	0.000357	0.0013	CcSEcCtD
Gemfibrozil—Convulsion—Methotrexate—lymphatic system cancer	0.000355	0.00129	CcSEcCtD
Gemfibrozil—Arthralgia—Methotrexate—lymphatic system cancer	0.000349	0.00127	CcSEcCtD
Gemfibrozil—Myalgia—Methotrexate—lymphatic system cancer	0.000349	0.00127	CcSEcCtD
Gemfibrozil—Chest pain—Methotrexate—lymphatic system cancer	0.000349	0.00127	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000346	0.00126	CcSEcCtD
Gemfibrozil—Confusional state—Methotrexate—lymphatic system cancer	0.000337	0.00123	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000334	0.00122	CcSEcCtD
Gemfibrozil—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000328	0.0012	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000327	0.00119	CcSEcCtD
Gemfibrozil—Skin disorder—Methotrexate—lymphatic system cancer	0.000325	0.00118	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000304	0.00111	CcSEcCtD
Gemfibrozil—Paraesthesia—Methotrexate—lymphatic system cancer	0.0003	0.00109	CcSEcCtD
Gemfibrozil—Somnolence—Methotrexate—lymphatic system cancer	0.000297	0.00108	CcSEcCtD
Gemfibrozil—Dyspepsia—Methotrexate—lymphatic system cancer	0.000294	0.00107	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000288	0.00105	CcSEcCtD
Gemfibrozil—Fatigue—Methotrexate—lymphatic system cancer	0.000288	0.00105	CcSEcCtD
Gemfibrozil—Pain—Methotrexate—lymphatic system cancer	0.000286	0.00104	CcSEcCtD
Gemfibrozil—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000275	0.001	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000273	0.000997	CcSEcCtD
Gemfibrozil—Urticaria—Methotrexate—lymphatic system cancer	0.000265	0.000968	CcSEcCtD
Gemfibrozil—Abdominal pain—Methotrexate—lymphatic system cancer	0.000264	0.000964	CcSEcCtD
Gemfibrozil—Asthenia—Methotrexate—lymphatic system cancer	0.00024	0.000875	CcSEcCtD
Gemfibrozil—Pruritus—Methotrexate—lymphatic system cancer	0.000236	0.000863	CcSEcCtD
Gemfibrozil—Diarrhoea—Methotrexate—lymphatic system cancer	0.000229	0.000834	CcSEcCtD
Gemfibrozil—Dizziness—Methotrexate—lymphatic system cancer	0.000221	0.000806	CcSEcCtD
Gemfibrozil—Vomiting—Methotrexate—lymphatic system cancer	0.000212	0.000775	CcSEcCtD
Gemfibrozil—Rash—Methotrexate—lymphatic system cancer	0.000211	0.000769	CcSEcCtD
Gemfibrozil—Dermatitis—Methotrexate—lymphatic system cancer	0.00021	0.000768	CcSEcCtD
Gemfibrozil—Headache—Methotrexate—lymphatic system cancer	0.000209	0.000764	CcSEcCtD
Gemfibrozil—Nausea—Methotrexate—lymphatic system cancer	0.000198	0.000724	CcSEcCtD
